2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Psychiatric Disorders: new trials by email Literature Review of Psychiatric Disorders trials Research Report on Psychiatric Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-release Trospium Chloride in Adolescents With Psychiatric Disorders KarXT, KarX-EC - Psychiatric Disorders | Phase 1 | Completed | Bristol-Myers Squibb | 24 | 2025-04-29 | 2025-08-06 |
| Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects OPC-34712 - Schizophrenia, Psychiatric Disorders | Phase 1 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 19 | 2011-01-01 | 2015-10-29 |
Mental Disorders (2) · Renal Insufficiency (1) · Schizophrenia (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Urogenital Diseases (1) · Urologic Diseases (1)
trospium chloride (1) · xanomeline (1)
Bristol-Myers Squibb (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
United States (2)